3-Bromopyridazine

HCID 13126699CAS 88491-61-6

Grundinformationen

Standard-SMILES
Brc1cccnn1
InChIKey
ILYSUJOMLYXAOC-UHFFFAOYSA-N
Summenformel
C4H3BrN2
Durchschnittliche Molmasse
158,98 g/mol
Monoisotopische Masse
157,94796

Namen und Bezeichner

Bevorzugter Name
3-Bromopyridazine
IUPAC
3-bromopyridazine
Englischer Name
Pyridazine, 3-bromo- (9CI)
Summenformel
C4H3BrN2
Molmasse
158.98

Namen und Synonyme

3-bromopyridazine88491-61-6DTXSID10520082RefChem:277796DTXCID80470888811-583-33-Bromo-pyridazineMFCD10688587Pyridazine, 3-bromo-SCHEMBL180986SCHEMBL209412SCHEMBL18938588
Weitere Namen anzeigen
3-bromo- (9CI)3-Bromopyridazine ,97%Pyridazine, 3-bromo- (9CI)3-broMopyridazine hydrobroMidePyridazine, 3-bromo- (9CI) ISO 9001:2015 REACH
SCHEMBL30828602ILYSUJOMLYXAOC-UHFFFAOYSA-NAKOS009548430CS-W004020FB72022GS-4388MB08580AC-25814

Datenbank-Bezeichner

CAS
88491-61-6
PubChem CID
13126699
DTXSID
DTXSID10520082
EC Number
811-583-3
Nikkaji
J1.002.398J

Eigenschaften

Berechnete Struktureigenschaften

XLogP
0,2
Polarare Oberfläche (TPSA)
25,8 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
2
Frei drehbare Bindungen
0
Schwere Atome
7

Physikochemische Eigenschaften

Schmelzpunkt
73 · 73-74 °C
Siedepunkt
270 · 270.0±13.0 °C(Predicted)
Dichte
1.726 · 1.726±0.06 g/cm3(Predicted)
storage temp.
-20 °C · Inert atmosphere,Store in freezer, under -20°C
Aggregatzustand
solid
pka
0.99 · 0.99±0.10(Predicted)

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 5 Einträge

Danger

H301+H311+H331 (16.7%): Toxic if swallowed, in contact with skin or if inhaled [Danger Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation];H302 (83.3%): Harmful if swallowed [Warning Acute toxicity, oral];H315 (66.7%): Causes skin irritation [Warning Skin corrosion/irritation];H318 (33.3%): Causes serious eye damage [Danger Serious eye damage/eye irritation];H319 (33.3%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H332 (50%): Harmful if inhaled [Warning Acute toxicity, inhalation];H335 (66.7%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]

P261, P262, P264, P264+P265, P270, P271, P280, P301+P316, P301+P317, P302+P352, P304+P340, P305+P351+P338, P305+P354+P338, P316, P317, P319, P321, P330, P332+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 6 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Gefahrenhinweise

Hazard Classes and CategoriesAcute Tox. 4 (83.3%);Skin Irrit. 2 (66.7%);Eye Dam. 1 (33.3%);Eye Irrit. 2A (33.3%);Acute Tox. 4 (50%);STOT SE 3 (66.7%)

Sicherheitsdaten

hs_code
2933998090
Speicherklasse
11 - Combustible Solids
Hazard Classifications
Acute Tox. 4 Oral

Chemie und Industrie

Anbieter50 Anbieter

郑州阿尔法化工有限公司+86-18530059196 · [email protected]
苏州道澜生物医药科技有限公司15952404857 · [email protected]
上海凌富药物研究有限公司+86(21)5895 0110 19945755304 · [email protected]
武汉英诺医药科技有限公司+86-027-59232304 15387063101 · [email protected]
毕佳索(上海毕得医药科技股份有限公司)400-6005915 · [email protected]

Zugehörige Reaktionen

2

Verknüpfte Notizen

Wird geladen…